Organization · Venture Studio
Emerald BioVentures
Emerald BioVentures is a life sciences incubator based in New York, focused on building companies that address complex medical challenges. It emphasizes innovation in healthcare through ideation and company formation.
Overview
What Emerald BioVentures does
What Emerald BioVentures is
Emerald BioVentures is a life sciences incubator based in New York, focused on building companies that address complex medical challenges. It emphasizes innovation in healthcare through ideation and company formation.
How it participates in the startup ecosystem
The current public profile supports funder and program host capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Studio
- Founded
- Founded in 2021
- Approximate age
- About 5 years
- Structured capabilities
- Funder · Program host
- Last reviewed
- March 27, 2026
What Venture studio means
A venture studio is an organization that systematically creates new startups by generating or sourcing ideas, validating them, building early products, recruiting founders or operators, providing shared resources, and retaining meaningful equity in the companies it helps create.
Open the glossary entryOfficial channels
Find Emerald BioVentures elsewhere
Open the official website or a supported primary organization account.
Capability profile
Emerald BioVentures as a funder
Investment thesis
Emerald BioVentures is a mission-driven life sciences incubator focused on building transformational companies in healthcare to improve human health through scientific advancements.
Focus narrative
Emerald BioVentures invests in companies that address complex medical issues such as neurodegenerative diseases, breast cancer, heart failure, and obesity. The organization seeks to identify and develop innovative solutions to these 'white space' problems, emphasizing a hands-on approach to company formation and growth.
Value beyond capital
Emerald BioVentures provides extensive operational support, capital advisory, and fundraising assistance to its portfolio companies. The team leverages over 25 years of experience in venture capital and commercializing university research, ensuring that companies receive the guidance needed to navigate the complexities of the life sciences sector.
Terms and economics
- Typical check
- $600,000
- Sweet spot
- $600,000
Focus and fit
- Stages
- Pre-seed · Seed · Seed+
- Regions
- United States
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 4
Portfolio context
Emerald BioVentures has invested in several notable companies, including: Aikium: Focused on inflammasome-related therapies. Avalo Therapeutics: Developing treatments for various conditions. BIOS: Specializes in biological innovations. Bond Biosciences: Concentrates on advancements in bioscience. eGlint: Involved in health technology solutions. Bask Health: A digital health platform for telehealth services. Health Outlook: Uses proteomics to enhance health predictions. Valorum Biologics: Develops biosimilars in ophthalmology and oncology.
Capability profile
Emerald BioVentures as a program host
Program thesis
Emerald BioVentures is a life sciences incubator focused on building transformational companies in healthcare, aiming to improve human health by leveraging advancements in science and medicine.
Focus narrative
Emerald BioVentures invests in companies that tackle complex medical issues, including neurodegenerative diseases, breast cancer, heart failure, and obesity. The organization seeks to identify and develop innovative solutions to these 'white space' problems.
Value and support
Emerald BioVentures offers mentorship, capital advisory, operational support, and access to a network of industry experts to help build and scale innovative healthcare companies.
Terms and economics
- Indicative investment
- $600,000
Availability
- Application state
- Not published
Focus and fit
- Stages
- Pre-seed · Seed
- Regions
- United States
Alumni and track record
Alumni context
Emerald BioVentures has invested in several notable companies, including Aikium, focused on inflammasome-related therapies; Avalo Therapeutics, developing treatments for various conditions; and Bask Health, a digital health platform facilitating telehealth services.
Common questions
What to know about Emerald BioVentures
Upseed classifies Emerald BioVentures under the Venture Studio organization type. Its current public profile includes funder and program host capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 27, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.